/C O R R E C T I O N — Eli Lilly and Company/

/C O R R E C T I O N -- Eli Lilly and Company/

PR Newswire

INDIANAPOLIS, July 9, 2026

In the news release, Lilly to present Alzheimer's disease diagnostic and therapeutic research at AAIC 2026, including new data on P-tau217 blood tests and amyloid-targeting treatment, issued July 9, 2026 by Eli Lilly and Company over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end:

Lilly to present Alzheimer's disease diagnostic and therapeutic research at AAIC 2026, including new data on P-tau217 blood tests and amyloid-targeting treatment